Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)

NCT02839889 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped The study was stopped due to challenges recruiting eligible patients.

Conditions

Cancer
Constipation
Pain

Interventions

DRUG: Naloxegol
DRUG: Placebo

Sponsor

Hospice of Henderson County, Inc.

Collaborators

[object Object]